SARS-CoV-2 Vaccination-Induced Transverse Myelitis
- PMID: 34458035
- PMCID: PMC8384391
- DOI: 10.7759/cureus.16624
SARS-CoV-2 Vaccination-Induced Transverse Myelitis
Abstract
While mass immunization against coronavirus disease 2019 (COVID-19) rolls out around the globe, safety concerns and adverse events that need prompt evaluation are also emerging. We report a case of transverse myelitis and Bell's palsy after receiving Johnson and Johnson COVID-19 vaccination under the emergency use authorization in a healthy young woman with no past medical history. Other possible etiologies of her symptoms were ruled out, and she was treated successfully with steroids and plasma exchange.
Keywords: bells palsy; covid 19; covid 19 vaccine; longitudinally extensive transverse myelitis; sars-cov-2; urinary retention.
Copyright © 2021, Tahir et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Proposed diagnostic criteria and nosology of acute transverse myelitis. Transverse Myelitis Consortium Working Group. Neurology. 2002;59:499–505. - PubMed
-
- The epidemiology of transverse myelitis. Bhat A, Naguwa S, Cheema G, Gershwin ME. Autoimmun Rev. 2010;9:0–9. - PubMed
-
- Micturition disturbance in acute transverse myelitis. Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Spinal Cord. 1996;34:481–485. - PubMed
-
- Transverse myelitis: pathogenesis, diagnosis and treatment. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Front Biosci. 2004;9:1483–1499. - PubMed
-
- Clinically isolated acute transverse myelitis: prognostic features and incidence. Young J, Quinn S, Hurrell M, Taylor B. Mult Scler. 2009;15:1295–1302. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous